360 likes | 601 Views
Clinical implementation of 3D EPID-based in vivo dose verification of IMRT/VMAT treatments. Ben Mijnheer. Disclosure.
E N D
Clinical implementation of 3D EPID-based in vivo dose verification of IMRT/VMAT treatments Ben Mijnheer
Disclosure The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital has a research cooperation with Elekta concerning the development of cone-beam CT and EPID dosimetry software
EPID-based in vivo 3D dose verification using a back-projection model 1) Calculate plan 2) Measure EPID dose 3) Reconstruct dose in multiple planes Patient CT 4) Compare planned and reconstructed 3D dose distribution
Clinical use of 3D EPID-based in vivo dosimetry • New software tools were clinically introduced to allow automated image acquisition, to periodically inspect the record-and-verify database, and to automatically run the EPID dosimetry software
Clinical use of 3D EPID-based in vivo dosimetry • New software tools were clinically introduced to allow automated image acquisition, to periodically inspect the record-and-verify database, and to automatically run the EPID dosimetry software • The comparison of the EPID-reconstructed and planned 3D dose distribution is done offlineand data are available a few minutes afterdelivery • Alerts are immediately raised, without any human intervention, when deviations are outside clinical criteria, and actions scheduled
Clinical use of 3D EPID-based in vivo dosimetry • New software tools were clinically introduced to allow automated image acquisition, to periodically inspect the record-and-verify database, and to automatically run the EPID dosimetry software • The comparison of the EPID-reconstructed and planned 3D dose distribution is done offlineand data are available a few minutesafterdelivery • Alerts are immediately raised, without any human intervention, when deviations are outside clinical criteria, and actions are scheduled
3D in vivo dose verification of prostate VMAT g automatic classification g-analysis statistics isoc dose (all arcs) 3D g-evaluation in the volume enclosed by the 50% isodose surface isoc dose
Clinical results of 3D EPID-based in vivo dosimetry (2012) 82% of the verified plans were within tolerance level (automatically approved)
Clinical results of 3D EPID-based in vivo dosimetry (2012) 82% of the verified plans were within tolerance level (automatically approved) 18% of the verified plans had at least one of the alert criteria outside tolerance level (limitation of transit dosimetry,
Breast IMRT: influence of setup error The problem The cause: 1.6 cm shift The solution: shift the measured images
Clinical results of 3D EPID-based in vivo dosimetry (2012) 82% of the verified plans were within tolerance level (automatically approved) 18% of the verified plans had at least one of the alert criteria outside tolerance level (limitation of transit dosimetry, tumor regression,
Head–and-neck VMAT: tumor regression After adding bolus, in vivo dosimetry showed that the dose was OK planning CT cone-beam CT
Clinical results of 3D EPID-based in vivo dosimetry (2012) 82% of the verified plans were within tolerance level (automatically approved) 18% of the verified plans had at least one of the alert criteria outside tolerance level (limitation of transit dosimetry, tumor regression, anatomical changes ….)
Lung step & shoot IMRT: recovery from atelectasis Based on the in vivo dosimetry and CBCT results it was decided to replan te patient
Clinical results of 3D EPID-based in vivo dosimetry (2012) 82% of the verified plans were within tolerance level (automatically approved) 18% of the verified plans had at least one of the alert criteria outside tolerance level (limitation of transit dosimetry, tumor regression, anatomical changes ….) 1/300 of the verified plans required immediate action (errors in the procedure in the clinic)
Head-and-neck VMAT: bolus not present during planning CT scan
Head-and-neck VMAT: bolus not present during planning CT scan New CT scan and plan: in vivo dosimetry OK!
Breast non-IMRT field: incorrect positioning of jaws “Something is wrong with the first field”
Breast non-IMRT fields: incorrect positioning of jaws “Something is wrong with the first field” Problem: A button “asymmetric beam” was accidentally ticked just before treatment, resulting in a symmetric adjustment of the backup jaws for one beam Action: Extra field for the remaining fractions
Online EPID-based 3D dose verification • By optimizing the dose reconstruction algorithm and the I/O performance, the delivered 3D dose distribution is verified in less than 200 ms per portal image, which includes the comparison between the reconstructed and planned dose distribution.
Online EPID-based 3D dose verification • By optimizing the dose reconstruction algorithm and the I/O performance, the delivered 3D dose distribution is verified in less than 200 ms per portal image, which includes the comparison between the reconstructed and planned dose distribution. • The RMS of the difference between the cumulative planned and reconstructed 3D dose distribution is used to generate a trigger that can stop the irradiation
Online EPID-based 3D dose verification • By optimizing the dose reconstruction algorithm and the I/O performance, the delivered 3D dose distribution is verified in less than 200 ms per portal image, which includes the comparison between the reconstructed and planned dose distribution. • The RMS of the difference between the cumulative planned and reconstructed 3D dose distribution is used to generate a trigger that can stop the irradiation • Irradiation of a polystyrene slab phantom with a 10 MV single arc VMAT prostate treatment when a serious error, the leaves were wide open, was introduced.
Conclusions • Our automatic offline EPID-based dosimetry tool facilitated the large scale clinical implementation of 3D in vivo dose verification of IMRT/VMAT treatments, and was able to trace clinically relevant errors
Conclusions • Our automatic offlineEPID-based dosimetry tool facilitated the large scale clinical implementation of 3D in vivo dose verification of IMRT/VMAT treatments, and was able to trace clinically relevant errors • It replaced pre-treatment verification, except for single fraction and large field treatments, and may safe resources for other purposes
Conclusions • Our automatic offline EPID-based dosimetry tool facilitated the large scale clinical implementation of 3D in vivo dose verification of IMRT/VMAT treatments, and was able to trace clinically relevant errors • It replaced pre-treatment verification, except for single fraction and large field treatments, and may safe resources for other purposes • Our online 3D in vivo dose verification approach can be used to halt the treatment machine in case of severe errors
Conclusions • Our automatic offline EPID-based dosimetry tool facilitated the large scale clinical implementation of 3D in vivo dose verification of IMRT/VMAT treatments, and was able to trace clinically relevant errors • It replaced pre-treatment verification, except for single fraction and large field treatments, and may safe resources for other purposes • Our online 3D in vivo dose verification approach can be used to halt the treatment machine in case of severe errors • 3D EPID-based in vivo dosimetry is a major step forward towards optimal quality and safety in radiation oncology practice
….. and special thanks to the EPID dosimetry group at NKI-AVL: • Anton Mans • Hanno Spreeuw • Igor Olaciregui-Ruiz • Jan-Jakob Sonke • Marcel van Herk • Patrick Gonzalez • René Tielenburg • Roel Rozendaal • Ron Vijlbrief
Future developments • To use deformable image registration algorithms to automate registration of CBCT scans to planning CT contours, calculate a new plan and compare the new 3D dose distribution with the measured 3D in vivo dosimetry results
Future developments • To use deformable image registration algorithms to automate registration of CBCT scans to planning CT contours, calculate a new plan and compare the new 3D dose distribution with the measured 3D in vivo dosimetry results • Preliminary results of the variation in plan characteristics during a series of VMAT treatments of 20 H&N patients showed only small changes in the D50 of the PTV
Future developments Incorporate setup deviations in the analysis Implement alert criteria based on DVH analysis (currently manual evaluation)